Edition:
United States

People: Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

1.30NOK
26 Sep 2017
Change (% chg)

kr0.00 (+0.00%)
Prev Close
kr1.30
Open
kr1.30
Day's High
kr1.32
Day's Low
kr1.30
Volume
5,000
Avg. Vol
39,651
52-wk High
kr2.50
52-wk Low
kr1.16

Framroze, Bomi 

Dr. Bomi Framroze has served as Chief Scientific Officer of Hofseth Biocare ASA since 2010. Dr. Framroze is a Discovery scientist with over 40 worldwide patents and publications in Life Science and Chemical software research. He has been an Associate Director of Chemical Discovery at American Cyanamid, an Executive Director at Gharda Chemicals Ltd. and was Founder/CSO of Row2Technologies Inc. Since 2004 he has been carrying out Discovery research in process technologies, biochemistry and marine ingredients.

Basic Compensation

Total Annual Compensation, NOK 5,266,000
Restricted Stock Awards, NOK --
Long-Term Incentive Plans, NOK --
All Other, NOK --
Fiscal Year Total, NOK 5,266,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ola Holen

--

Roger Hofseth

542,000

Jon Odegard

1,774,000

Matt Mixter

1,090,000

Bomi Framroze

5,266,000

Kai Thuen

902,000
As Of  30 Dec 2015